Table 3.
Matching* | Number treated | Centers | Cohort | HR | P value | 95% CI |
---|---|---|---|---|---|---|
1:5 | 657 | All | Tacrolimus only/belatacept only | 0.84 | 0.28 | 0.61-1.15 |
1:5 | 1,192 | All | Tacrolimus only/all belatacept | 0.90 | 0.45 | 0.70-1.17 |
1:5 | 214 | Belatacept study centers only | Tacrolimus only/belatacept only | 0.97 | 0.91 | 0.52-1.79 |
1:5 | 703 | Belatacept study centers only | Tacrolimus only/all belatacept | 0.94 | 0.72 | 0.65-1.35 |
1:5 | 648 | Matched on center | Tacrolimus only/belatacept only | 0.85 | 0.33 | 0.61-1.18 |
1:5 | 1,182 | Matched on center | Tacrolimus only/all belatacept | 0.88 | 0.35 | 0.68-1.14 |
Matched on recipient age, recipient ethnicity, male sex, dialysis vintage, recipient diabetes, donor age, donor height, donor weight, donor race, donor hypertension, donor diabetes, donor HCV, deceased donor, and induction.